Marjanka Schmidt

Marjanka leads the "Early Detection" program at the NKI, which aims to develop, coordinate and support excellent research and strengthen the collective and interdisciplinary mission to improve early detection of cancer. Within this role, she also drives strategic initiatives to enhance the impact of early detection research within the institute and in (inter)national collaboration.

Marjanka is also the Head of the Division of Molecular Pathology at the NKI, where her research group is based, and a professor of Genetic Epidemiology of (breast)cancer at Leiden University. Her research group is dedicated to investigating the impact of genetic variants on the risk, prognosis, and long-term outcomes of breast cancer subtypes. Her work integrates epidemiological and molecular research to advance personalized medicine, aiming to develop preventive and therapeutic interventions tailored to an individual’s genetic profile.